This book discusses discoveries that have the potential to revolutionize your clinical approach by changing the ways in which you diagnose and treat patients. Clinicians will learn about the effects on psychiatry of advances in the molecular basis of neuronal network function and the identification of novel molecular targets for drug development.

In this authoritative volume you'll find today's most important molecular neurobiological advances and their relevance to clinicians treating patients with mental illness. Molecular Neurobiology for the Clinician, Review of Psychiatry, Volume 22, will update you on the latest findings -- and their impact on psychiatry.

You'll learn about • Discoveries with the potential to revolutionize your clinical approach by changing the ways in which you diagnose and treat patients• The effects on psychiatry of advances in the molecular basis of neuronal network function, particularly in relation to abnormalities in cognitive and emotional regulation, and the identification of novel molecular targets for drug development• How to apply these discoveries to diagnosing and treating major psychiatric disorders, including childhood- and adolescent-onset disorders, schizophrenia, drug addiction, and severe mood and anxiety disorders

Molecular Neurobiology for the Clinician is an outstanding compilation of the best research by top names in the field. Psychiatrists, psychologists, psychiatric residents, and graduate students in neuroscience, psychiatry, and psychology will gain knowledge, understanding, and techniques for better diagnosis and treatment.

ContributorsIntroduction to the Review of Psychiatry SeriesPrefaceChapter 1. Molecular neurobiology of childhood- and adolescent-onset psychiatric disordersChapter 2. Molecular genetics: a role in diagnosis and treatment of psychiatric disorders?Chapter 3. Molecular neurobiology and schizophrenia: implications for etiology and treatmentChapter 4. Molecular mechanisms of drug addictionChapter 5. Cellular neurobiology of severe mood and anxiety disorders: implications for development of novel therapeuticsIndex